AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 97 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $71,289,926 | -45.5% | 20,485,611 | 0.0% | 0.30% | -43.6% |
| Q1 2024 | $130,698,198 | -0.9% | 20,485,611 | 0.0% | 0.53% | -11.0% |
| Q4 2023 | $131,927,335 | +176.4% | 20,485,611 | 0.0% | 0.59% | +196.5% |
| Q3 2023 | $47,731,474 | -2.1% | 20,485,611 | 0.0% | 0.20% | -4.3% |
| Q2 2023 | $48,755,754 | +29.3% | 20,485,611 | 0.0% | 0.21% | +35.7% |
| Q1 2023 | $37,693,524 | -3.2% | 20,485,611 | 0.0% | 0.15% | +4.1% |
| Q4 2022 | $38,922,661 | +101026.7% | 20,485,611 | +13.9% | 0.15% | +4.2% |
| Q3 2022 | $38,489 | -99.9% | 17,985,611 | 0.0% | 0.14% | -16.0% |
| Q2 2022 | $50,899,000 | -32.1% | 17,985,611 | 0.0% | 0.17% | -11.1% |
| Q1 2022 | $75,000,000 | -19.7% | 17,985,611 | 0.0% | 0.19% | -18.8% |
| Q4 2021 | $93,345,000 | – | 17,985,611 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 7,346,829 | $15,723,000 | 27.32% |
| TFG Asset Management GP Ltd | 3,039,381 | $6,504,000 | 0.78% |
| Nantahala Capital Management | 5,215,788 | $11,162,000 | 0.72% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,018,000 | 0.62% |
| HARBOR CAPITAL ADVISORS, INC. | 148,454 | $318,000 | 0.29% |
| DAFNA Capital Management LLC | 496,150 | $1,062,000 | 0.29% |
| Blackstone Inc. | 17,985,611 | $38,489 | 0.14% |
| Ikarian Capital, LLC | 260,087 | $556,000 | 0.11% |
| MYDA Advisors LLC | 100,000 | $214,000 | 0.10% |
| Privium Fund Management B.V. | 113,528 | $253,000 | 0.09% |